Literature DB >> 26378682

Descriptive epidemiology of spot urine sodium-to-potassium ratio clarified close relationship with blood pressure level: the Nagahama study.

Yasuharu Tabara1, Yoshimitsu Takahashi, Kyoko Kumagai, Kazuya Setoh, Takahisa Kawaguchi, Meiko Takahashi, Yuki Muraoka, Akitaka Tsujikawa, Norimoto Gotoh, Chikashi Terao, Ryo Yamada, Shinji Kosugi, Akihiro Sekine, Nagahisa Yoshimura, Takeo Nakayama, Fumihiko Matsuda.   

Abstract

OBJECTIVES: We undertook descriptive epidemiology of spot urine sodium-to-potassium ratio (Na/K) in a population sample to clarify the close relationship between Na/K and blood pressure level independently of potential confounding factors.
METHODS: Study participants consisted of 9144 apparently healthy citizens (aged 54 ± 13 years). All clinical parameters were obtained at baseline.
RESULTS: Na/K was significantly higher in hypertensive individuals irrespective of antihypertensive medication status (normotension, 3.12 ± 1.82; untreated hypertension 3.50 ± 1.96; treated hypertension, 3.72 ± 2.53). As urinary Na (β = 0.092, P < 0.001) and K (β = -0.050, P < 0.001) levels were inversely associated with BP, Na/K (β = 0.118, P < 0.001) was more closely associated with BP than Na or K alone, as well as daily salt intake estimated from urinary Na (β = 0.088, P < 0.001). Several factors were significantly associated with Na/K, namely age, sex, obesity, blood pressure, renal function, salt restriction status, serum phosphate and urinary creatinine level, and fasting period and season at urine sample collection. However, the association between Na/K and BP was independent of these factors (adjusted β = 0.112, P < 0.001). No direct association was observed between Na/K and large arterial remodeling assessed by pulse wave analysis (P = 0.496) or retinal arteriolar morphological change (P = 0.431). Further, a genome-wide association study failed to identify any particular genotype influencing urinary Na and K levels.
CONCLUSIONS: Although we clarified several factors that might affect spot urine Na/K, these relationships were not substantial enough to confound the association between urinary Na/K and BP. A simple measure of Na/K might be more representative of salt loading obtained from spot urine samples than Na excretion alone.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26378682     DOI: 10.1097/HJH.0000000000000734

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  22 in total

Review 1.  Does Potassium Deficiency Contribute to Hypertension in Children and Adolescents?

Authors:  Bonita Falkner
Journal:  Curr Hypertens Rep       Date:  2017-05       Impact factor: 5.369

2.  The spot urine sodium-to-potassium ratio as a marker of hypertension risk.

Authors:  Yasuharu Tabara
Journal:  Hypertens Res       Date:  2022-02-25       Impact factor: 3.872

Review 3.  Dietary Reference Intakes of sodium for Koreans: focusing on a new DRI component for chronic disease risk reduction.

Authors:  Hyun Ja Kim; Yeon-Kyung Lee; Hoseok Koo; Min-Jeong Shin
Journal:  Nutr Res Pract       Date:  2022-03-16       Impact factor: 1.992

4.  Genome-Wide Association Meta-Analysis of Individuals of European Ancestry Identifies Suggestive Loci for Sodium Intake, Potassium Intake, and Their Ratio Measured from 24-Hour or Half-Day Urine Samples.

Authors:  Minjung Kho; Jennifer A Smith; Niek Verweij; Lulu Shang; Kathleen A Ryan; Wei Zhao; Erin B Ware; Ron T Gansevoort; Marguerite R Irvin; Jung Eun Lee; Stephen T Turner; Joohon Sung; Pim van der Harst; Donna K Arnett; Ana Baylin; Sung Kyun Park; Young Ah Seo; Kristen M Kelly; Yen Pei C Chang; Xiang Zhou; John C Lieske; Sharon L R Kardia
Journal:  J Nutr       Date:  2020-10-12       Impact factor: 4.798

5.  The association of arterial stiffness with estimated excretion levels of urinary sodium and potassium and their ratio in Chinese adults.

Authors:  Qinyu Yang; Weihong Jiang; Yongmei He; Lin Yang; Congke Zhao; Lijun Li; Pingting Yang; Lu Yin; Xiaohui Li; Xin Huang; Ying Li
Journal:  J Hum Hypertens       Date:  2022-03-25       Impact factor: 3.012

6.  Association of Salt-Reduction Knowledge and Behaviors and Salt Intake in Chinese Population.

Authors:  Bing Han; Chuancang Li; Yabing Zhou; Mengge Zhang; Yang Zhao; Ting Zhao; Dongsheng Hu; Liang Sun
Journal:  Front Public Health       Date:  2022-04-18

Review 7.  Potassium and Obesity/Metabolic Syndrome: A Systematic Review and Meta-Analysis of the Epidemiological Evidence.

Authors:  Xianlei Cai; Xueying Li; Wenjie Fan; Wanqi Yu; Shan Wang; Zhenhong Li; Ethel Marian Scott; Xiuyang Li
Journal:  Nutrients       Date:  2016-03-25       Impact factor: 5.717

8.  Association of urinary sodium/potassium ratio with structural and functional vascular changes in non-diabetic hypertensive patients.

Authors:  Michelle R Cunha; Ana R Cunha; Bianca C A A Marques; Samanta S Mattos; Jenifer D'El-Rei; Natalia M França; Wille Oigman; Mario F Neves
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-08-24       Impact factor: 3.738

9.  Comment on "Urinary sodium-to-potassium ratio associates with hypertension and current disease activity in patients with rheumatoid arthritis: a cross-sectional study": authors' reply.

Authors:  Hiroto Minamino; Motomu Hashimoto; Masao Katsushima; Yoshihito Fujita
Journal:  Arthritis Res Ther       Date:  2021-07-21       Impact factor: 5.156

Review 10.  Novelty in hypertension in children and adolescents: focus on hypertension during the first year of life, use and interpretation of ambulatory blood pressure monitoring, role of physical activity in prevention and treatment, simple carbohydrates and uric acid as risk factors.

Authors:  Mirella Strambi; Marco Giussani; Maria Amalia Ambruzzi; Paolo Brambilla; Ciro Corrado; Ugo Giordano; Claudio Maffeis; Silvio Maringhin; Maria Chiara Matteucci; Ettore Menghetti; Patrizia Salice; Federico Schena; Pietro Strisciuglio; Giuliana Valerio; Francesca Viazzi; Raffaele Virdis; Simonetta Genovesi
Journal:  Ital J Pediatr       Date:  2016-07-16       Impact factor: 2.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.